CD19: A multifunctional immunological target molecule and its implications for Blineage acute lymphoblastic leukemia.

Weiland, Judith; Elder, Alex; Forster, Victoria; Heidenreich, Olaf; Koschmieder, Steffen; Vormoor, Josef

Weiland, Judith; Elder, Alex; Forster, Victoria; Heidenreich, Olaf; Koschmieder, Steffen; Vormoor, Josef.

Afiliação

Weiland J; Northern Institute for Cancer Research, Newcastle University, Newcastle-upon-Tyne, UK.
Elder A; Faculty of Medicine, RWTH Aachen University, Aachen, Germany.
Forster V; Northern Institute for Cancer Research, Newcastle University, Newcastle-upon-Tyne, UK.
Heidenreich O; Northern Institute for Cancer Research, Newcastle University, Newcastle-upon-Tyne, UK.
Koschmieder S; Northern Institute for Cancer Research, Newcastle University, Newcastle-upon-Tyne, UK.
Vormoor J; Department of Hematology, Oncology, Hemostaseology, and Stem Cell Transplantation, Faculty of Medicine, RWTH Aachen University, Aachen, Germany.

Pediatr Blood Cancer ; 62(7): 1144-8, 2015 Jul.

Article em En | MEDLINE | ID: mdl-25755168

Assuntos

Anticorpos Biespecíficos/farmacologia; Antígenos CD19/imunologia; Antineoplásicos/farmacologia; Leucemia-Linfoma Linfoblástico de Células Precursoras B/tratamento farmacológico; Adulto; Antígenos CD19/química; Ensaios Clínicos como Assunto; Humanos; Leucemia-Linfoma Linfoblástico de Células Precursoras B/imunologia

Palavras-chave

BCP-ALL; CD19; blinatumomab; childhood leukemia; pre-BCR

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Leucemia-Linfoma Linfoblástico de Células Precursoras B / Anticorpos Biespecíficos / Antígenos CD19 / Antineoplásicos Idioma: En Ano de publicação: 2015 Tipo de documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google